These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 20139023)
1. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade. Godal R; Bachanova V; Gleason M; McCullar V; Yun GH; Cooley S; Verneris MR; McGlave PB; Miller JS Biol Blood Marrow Transplant; 2010 May; 16(5):612-21. PubMed ID: 20139023 [TBL] [Abstract][Full Text] [Related]
2. Partial break in tolerance of NKG2A Rathmann S; Keck C; Kreutz C; Weit N; Müller M; Timmer J; Glatzel S; Follo M; Malkovsky M; Werner M; Handgretinger R; Finke J; Fisch P Bone Marrow Transplant; 2017 Aug; 52(8):1144-1155. PubMed ID: 28481352 [TBL] [Abstract][Full Text] [Related]
3. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671 [TBL] [Abstract][Full Text] [Related]
4. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation. Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012 [TBL] [Abstract][Full Text] [Related]
5. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415 [TBL] [Abstract][Full Text] [Related]
6. Liu LL; Béziat V; Oei VYS; Pfefferle A; Schaffer M; Lehmann S; Hellström-Lindberg E; Söderhäll S; Heyman M; Grandér D; Malmberg KJ Cancer Immunol Res; 2017 Aug; 5(8):654-665. PubMed ID: 28637877 [TBL] [Abstract][Full Text] [Related]
7. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
8. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Ponte M; Cantoni C; Biassoni R; Tradori-Cappai A; Bentivoglio G; Vitale C; Bertone S; Moretta A; Moretta L; Mingari MC Proc Natl Acad Sci U S A; 1999 May; 96(10):5674-9. PubMed ID: 10318943 [TBL] [Abstract][Full Text] [Related]
10. Reciprocal age related change in natural killer cell receptors for MHC class I. Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327 [TBL] [Abstract][Full Text] [Related]
11. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654 [TBL] [Abstract][Full Text] [Related]
12. Microchip-Based Single-Cell Imaging Reveals That CD56dimCD57-KIR-NKG2A+ NK Cells Have More Dynamic Migration Associated with Increased Target Cell Conjugation and Probability of Killing Compared to CD56dimCD57-KIR-NKG2A- NK Cells. Forslund E; Sohlberg E; Enqvist M; Olofsson PE; Malmberg KJ; Önfelt B J Immunol; 2015 Oct; 195(7):3374-81. PubMed ID: 26320254 [TBL] [Abstract][Full Text] [Related]
13. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant. Lin Chua H; Brahmi Z Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268 [TBL] [Abstract][Full Text] [Related]
14. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650 [TBL] [Abstract][Full Text] [Related]
15. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities. Diermayr S; Himmelreich H; Durovic B; Mathys-Schneeberger A; Siegler U; Langenkamp U; Hofsteenge J; Gratwohl A; Tichelli A; Paluszewska M; Wiktor-Jedrzejczak W; Kalberer CP; Wodnar-Filipowicz A Blood; 2008 Feb; 111(3):1428-36. PubMed ID: 17993609 [TBL] [Abstract][Full Text] [Related]
16. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Nguyen S; Dhedin N; Vernant JP; Kuentz M; Al Jijakli A; Rouas-Freiss N; Carosella ED; Boudifa A; Debré P; Vieillard V Blood; 2005 May; 105(10):4135-42. PubMed ID: 15687235 [TBL] [Abstract][Full Text] [Related]
17. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671 [TBL] [Abstract][Full Text] [Related]